Trials / Conditions / EGFR Mutation-Related Tumors
EGFR Mutation-Related Tumors
5 registered clinical trials studyying EGFR Mutation-Related Tumors.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lu NCT06685718 | BeOne Medicines | Phase 1 |
| Unknown | EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer NCT05498389 | Shanghai EpimAb Biotherapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer NCT05514496 | Nalo Therapeutics Inc. | Phase 1 |
| Completed | Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer NCT06525246 | Ono Pharmaceutical Co., Ltd. | Phase 1 |
| Unknown | Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC NCT04304638 | Chinese Academy of Medical Sciences | — |